Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m very interested I you assessment here and looking at the 90 million shares at the top of the chart. Would I be correct to believe that is where your expecting the outstanding shares to be at in the future? Please correct me if I’ve misunderstood.
Thank you I was having issues trying to listen to today’s CC.
Will do thanks!!!
Is there a link or a previous post I may have missed which would suggest the revenue stream that could come from Rhett’s patients for AV?
Has there been any sort of value placed on the potential Rhett’s income realizing we have not established a cost to 2-73.
That would be simply amazing, I wouldn’t have guessed today’s AH price would happen so who knows.
Posing a question The AH activity, could this be shorts coving?
That would be very nice!!!
It’s all good nothing goes strait up, this I would say is healthy trading.
Anyone see the headline for Biogen and the pre market up almost $90 a share.
(Bloomberg) -- Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of data from two failed clinical trials showed promising results.
The move by Biogen -- if successful -- would be the drug industry’s most dramatic reversal of fortune in history. The company said it made the decision after talking with the U.S. Food and Drug Administration and reviewing data showing the therapy helped Alzheimer’s patients’ cognitive function and their ability to perform basic tasks.
Someone on IHub had mentioned he threw out some negative spin on edibles right after Health Canada updated our licence Friday. He had said it on the Todd Shapiro show on the Saturday, which I haven’t listened to yet. Frequently in the corporate world they soften the departure so it’s not ugly when things are not cohesive in the vision.
Why would an executive leave now if NXTTF was doing well?
For other opportunities?
He knows the coming disaster.
====================
“Bailing” LoL
You have no clue what’s going on.
https://cannmart.co.uk/ Is up says coming soon and is seeking email addresses.
I understand the necessity to provide a PR so all are aware and no one gains an advantage. If there is expanded information to be provided when would that occur. The time difference would allow someone attending to know at 3:00 am local time and in North America we wouldn’t find out until the PR was given prior to trading here. Does this provide a pre market advantage to an attendee?
Does this company have shares that can be traded?
Thank you so much & we know who it’s needed for!!!
Here is the link.
https://medium.com/namaste-tech-blog
Christopher U. Missling, PhD, will present at the H.C. Wainwright Annual Global Life Sciences Conference on Monday, April 8, 2019 at 9:30 a.m. BST. The conference will be held at the Grosvenor House in London, UK.
That’s what I see happening, it’s being spun as a negative to be addressing so many diseases but in fact that’s the cement in the overall field. When you display several trials accomplishing the same thing that what gets the results and approvals. Ya you can target one thing and possibly do very well but when multiple events are positive that removes so many doubts. There are still end point to show proof yes but the the likely hood of success is shifting.
I commented to a fellow investor yesterday that the 1 million that traded early in the first half hour will not be available for the time being until we are at least over $4 and even then......
I think he was of the belief that the trials were going to happen, then the quagmire of bureaucracy happened forcing the trials to be re located. If they had moved on the timeline TGD had envisioned we would have needed the blank cheque already.
Given what you said I recall, all be it I may have misunderstood but the preferred shares were to be available to the board and could be converted, issued to current shareholders as a tool to make it very expensive for a take over. I can’t recall the exact ratio but it gave the opportunity to increase your position by 1 share for every 2 held I think.
Not likely at all, the company didn’t repeat what happened the last 2 years and wait till the last minute and not file, although similar it’s very different with the disclosure previously made.
Then quite frankly if an entity who knows the rules of accounting and reporting can’t decide if a “reportable even” has taken place, I’m gonna say it’s a PR excuse nothing more. They had to say something so let’s give a real vague response that no one will be able confirm or denie neither PWC or N, or anyone else for that matter so I’m not so sure they really have anything, just how I see it.
Totally agree they have there own dirty laundry to deal with, so in the end the audited numbers will be telling. That being said the biggest unknown which is the source all the negative Nancy’s post is the reason / motives for the resignation, unless that is made known and it won’t be the numbers are what matter!
The host mentions last visit was April 4th of this year so I’d have to believe that was 2018 so do we know the actual date this was recorded, obviously later in 2018 so not maybe as current / recent as one may think?
I was referring to the time when it’s @ $100 would you not evaluate the current status, say 3-71 was about to come on line I’d hold past that figure.
That would be a possibility but would you not consider the current state of operations before you did that?
My take on this extension for what it’s worth the Dr. is leading all to understand the trial “didn’t fail quickly” as he has stated was his aim in past presentations. The inference is, it’s working, when you add in to the overall equation that we have 3 trials on going it supports the affirmative as opposed to the negative, without coming right out and saying as much.
Thanks for the # called and voted in favour.
31 March or before, it was showing 13 March on BNN which was previously saying 27 Feb.
Call IR they are passing on info from people who didn’t get the package, such as myself.